  | CHEMLA, A., ARENA, G., SACRIPANTI, G., BARMPA, K., ZAGARE, A., GARCIA, P., GORGOGIETAS, V., ANTONY, P., OHNMACHT, J., BARON, A., Jung, J., Lind-Holm Mogensen, F., MICHELUCCI, A., MARZESCO, A.-M., BUTTINI, M., Schmidt, T., GRÜNEWALD, A., SCHWAMBORN, J. C., KRÜGER, R., & SARAIVA, C. (03 October 2025). Parkinson's disease mutant Miro1 causes mitochondrial dysfunction and dopaminergic neuron loss. Brain: a Journal of Neurology, 148 (10), 3607 - 3622. doi:10.1093/brain/awaf051  Peer Reviewed verified by ORBi |
 | ZAGARE, A., SAUTER, T., BARMPA, K., PIRES PACHECO, M. I., KRÜGER, R., SCHWAMBORN, J. C., & SARAIVA, C. (17 April 2025). MIRO1 mutation leads to metabolic maladaptation resulting in Parkinson's disease-associated dopaminergic neuron loss. NPJ Systems Biology and Applications, 11 (1), 37. doi:10.1038/s41540-025-00509-x Peer Reviewed verified by ORBi |
 | ZAGARE, A., BALAUR, I.-A., ROUGNY, A., SARAIVA, C., GOBIN, M., MONZEL, A. S., GHOSH, S., SATAGOPAM, V., & SCHWAMBORN, J. C. (31 March 2025). Deciphering shared molecular dysregulation across Parkinson's disease variants using a multi-modal network-based data integration and analysis. NPJ Parkinson's Disease, 11 (1), 63. doi:10.1038/s41531-025-00914-3 Peer Reviewed verified by ORBi |
 | BARMPA, K., SARAIVA, C., Lopez-Pigozzi, D., Gomez-Giro, G., Gabassi, E., Spitz, S., Brandauer, K., Rodriguez Gatica, J. E., ANTONY, P., ROBERTSON, G., Sabahi-Kaviani, R., Bellapianta, A., Papastefanaki, F., Luttge, R., Kubitscheck, U., Salti, A., Ertl, P., Bortolozzi, M., Matsas, R., ... SCHWAMBORN, J. C. (23 November 2024). Modeling early phenotypes of Parkinson's disease by age-induced midbrain-striatum assembloids. Communications Biology, 7 (1), 1561. doi:10.1038/s42003-024-07273-4 Peer Reviewed verified by ORBi |
 | CHEMLA, A., ARENA, G., SARAIVA, C., Berenguer-Escuder, C., Grossmann, D., GRÜNEWALD, A., Klein, C., Seibler, P., SCHWAMBORN, J. C., & KRÜGER, R. (2023). Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson's disease patients carrying the heterozygous mutations c.1290A > G (p.T351A) or c.2067A > G (p.T610A) in the RHOT1 gene encoding Miro1. Stem Cell Research, 69, 103085. doi:10.1016/j.scr.2023.103085 Peer Reviewed verified by ORBi |
 | GARCIA SANTA CRUZ, B., Sölter, J., GOMEZ GIRO, G., SARAIVA, C., SABATÉ SOLER, S., Modamio Chamarro, J., BARMPA, K., SCHWAMBORN, J. C., HERTEL, F., JARAZO, J., & HUSCH, A. (2022). Generalising from conventional pipelines using deep learning in high‑throughput screening workfows. Scientific Reports. doi:10.1038/s41598-022-15623-7 Peer Reviewed verified by ORBi |
 | SABATÉ SOLER, S., NICKELS, S. L., SARAIVA, C., Berger, E., Dubonyte, U., BARMPA, K., Lan, Y. J., Kouno, T., JARAZO, J., ROBERTSON, G., Sharif, J., Koseki, H., Thome, C., Shin, J., Cowley, S., & SCHWAMBORN, J. C. (2022). Microglia integration into human midbrain organoids leads to increased neuronal maturation and functionality. Glia. doi:10.1002/glia.24167 Peer Reviewed verified by ORBi |
  | JARAZO, J., BARMPA, K., Modamio, J., SARAIVA, C., SABATÉ SOLER, S., ROSETY, I., Griesbeck, A., Skwirblies, F., Zaffaroni, G., SMITS, L., Su, J., Arias-Fuenzalida, Walter, J., GOMEZ GIRO, G., Monzel, A., Qing, X., VITALI, A., CRUCIANI, G., BOUSSAAD, I., ... SCHWAMBORN, J. C. (2021). Parkinson’s disease phenotypes in patient neuronal cultures and brain organoids improved by 2-Hydroxypropyl-b-Cyclodextrin treatment. Movement Disorders. doi:10.1002/mds.28810 Peer Reviewed verified by ORBi |
 | GARCIA SANTA CRUZ, B., JARAZO, J., SARAIVA, C., GOMEZ GIRO, G., MODAMIO CHAMARRO, J., SABATÉ SOLER, S., Kyriaki, B., ANTONY, P., SCHWAMBORN, J. C., HERTEL, F., & HUSCH, A. (29 November 2019). From tech to bench: Deep Learning pipeline for image segmentation of high-throughput high-content microscopy data [Poster presentation]. Advances in Computational Biology, Barcelona, Spain. |